EHMT2 and breast neoplasm: Tu and colleagues demonstrated the interaction between c‐Myc and G9a in basal breast tumours whereby G9a inhibition suppresses c‐Myc‐dependent tumour growth, suggesting that G9a is an important epigenetic modulator of c‐Myc transcriptional repression [22].